CA2818327A1 - Methode et systeme d'essai d'analytes avec notification de comportements marques ou faibles des analytes - Google Patents

Methode et systeme d'essai d'analytes avec notification de comportements marques ou faibles des analytes Download PDF

Info

Publication number: CA2818327A1
Authority: CA; Canada
Prior art keywords: analyte; screen; threshold; trend; measurement
Prior art date: 2010-11-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2818327A

Other languages

English (en)

Inventor

Jeremy Landis

Salve Retuta Pascual

Anita Mathew

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

LifeScan Inc

Original Assignee

LifeScan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-11-19

Filing date

2011-11-04

Publication date

2012-05-24

2011-05-31 Priority claimed from US29/393,126 external-priority patent/USD709901S1/en

2011-07-27 Priority claimed from US13/192,348 external-priority patent/US20120130646A1/en

2011-11-04 Application filed by LifeScan Inc filed Critical LifeScan Inc

2012-05-24 Publication of CA2818327A1 publication Critical patent/CA2818327A1/fr

Status Abandoned legal-status Critical Current

Links

239000012491 analyte Substances 0.000 title claims abstract description 231
238000012360 testing method Methods 0.000 title claims description 35
238000000034 method Methods 0.000 claims abstract description 60
206010012601 diabetes mellitus Diseases 0.000 claims abstract description 14
238000005259 measurement Methods 0.000 claims description 224
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 90
239000008103 glucose Substances 0.000 claims description 90
239000008280 blood Substances 0.000 claims description 62
210000004369 blood Anatomy 0.000 claims description 62
235000012054 meals Nutrition 0.000 claims description 48
238000010295 mobile communication Methods 0.000 claims description 32
230000008569 process Effects 0.000 claims description 22
239000012530 fluid Substances 0.000 claims description 19
239000006227 byproduct Substances 0.000 claims description 8
230000002255 enzymatic effect Effects 0.000 claims description 8
230000005055 memory storage Effects 0.000 claims description 6
230000009466 transformation Effects 0.000 claims description 5
230000000977 initiatory effect Effects 0.000 claims description 4
230000003247 decreasing effect Effects 0.000 claims description 2
230000001131 transforming effect Effects 0.000 claims description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 74
238000004891 communication Methods 0.000 description 9
238000001514 detection method Methods 0.000 description 8
230000006870 function Effects 0.000 description 8
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
239000007787 solid Substances 0.000 description 8
238000004458 analytical method Methods 0.000 description 6
150000001720 carbohydrates Chemical class 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
229940079593 drug Drugs 0.000 description 5
239000003814 drug Substances 0.000 description 5
230000036541 health Effects 0.000 description 5
238000007726 management method Methods 0.000 description 5
102000004877 Insulin Human genes 0.000 description 4
108090001061 Insulin Proteins 0.000 description 4
229940125396 insulin Drugs 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 4
238000012546 transfer Methods 0.000 description 4
238000009534 blood test Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000012913 prioritisation Methods 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
229940123452 Rapid-acting insulin Drugs 0.000 description 2
108010026951 Short-Acting Insulin Proteins 0.000 description 2
238000013459 approach Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
235000021152 breakfast Nutrition 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
238000013500 data storage Methods 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
239000011714 flavin adenine dinucleotide Substances 0.000 description 2
-1 for example Substances 0.000 description 2
150000002303 glucose derivatives Chemical class 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
201000004569 Blindness Diseases 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
208000002249 Diabetes Complications Diseases 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
208000028389 Nerve injury Diseases 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
238000004590 computer program Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000000840 electrochemical analysis Methods 0.000 description 1
YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000012631 food intake Nutrition 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000001788 irregular Effects 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
230000008764 nerve damage Effects 0.000 description 1
238000005192 partition Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000010079 rubber tapping Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1

Classifications

- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Primary Health Care (AREA)
Business, Economics & Management (AREA)
General Business, Economics & Management (AREA)
Data Mining & Analysis (AREA)
Databases & Information Systems (AREA)
Pathology (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
User Interface Of Digital Computer (AREA)

CA2818327A 2010-11-19 2011-11-04 Methode et systeme d'essai d'analytes avec notification de comportements marques ou faibles des analytes Abandoned CA2818327A1 (fr)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US41559810P	2010-11-19	2010-11-19
US61/415,598		2010-11-19
US201161469046P	2011-03-29	2011-03-29
US61/469,046		2011-03-29
US29/393,126		2011-05-31
US29/393,126 USD709901S1 (en)	2011-05-31	2011-05-31	Display screen with computer icon for blood glucose monitoring
US13/192,348 US20120130646A1 (en)	2010-11-19	2011-07-27	Analyte testing method and system with high and low analyte trends notification
US13/192,348		2011-07-27
PCT/US2011/059416 WO2012067854A2 (fr)	2010-11-19	2011-11-04	Méthode et système d'essai d'analytes avec notification de comportements marqués ou faibles des analytes

Publications (1)

Publication Number	Publication Date
CA2818327A1 true CA2818327A1 (fr)	2012-05-24

Family

ID=46084572

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2818327A Abandoned CA2818327A1 (fr)	2010-11-19	2011-11-04	Methode et systeme d'essai d'analytes avec notification de comportements marques ou faibles des analytes

Country Status (7)

Country	Link
JP (1)	JP5855118B2 (fr)
CN (1)	CN103561634B (fr)
AU (1)	AU2011329302B2 (fr)
BR (1)	BR112013012462A2 (fr)
CA (1)	CA2818327A1 (fr)
RU (1)	RU2013127664A (fr)
WO (1)	WO2012067854A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10453573B2 (en)	2012-06-05	2019-10-22	Dexcom, Inc.	Dynamic report building
HK1219036A1 (zh) *	2013-03-12	2017-03-24	F. Hoffmann-La Roche Ag	用於传输葡萄糖测量的方法、用於在葡萄糖测量的无线传输期间显示状态的方法和手持葡萄糖计
US20140379360A1 (en) *	2013-06-25	2014-12-25	Lifescan, Inc.	Low glucose treatment for people with diabetes
US9482635B2 (en) *	2013-06-25	2016-11-01	Animas Corporation	Glucose-measurement systems and methods presenting icons
EP3128913B1 (fr) *	2014-04-10	2019-05-08	Dexcom, Inc.	Détermination d'un indice d'urgence d'utilisateur associé à un état physiologique
JP7250423B2 (ja)	2015-07-06	2023-04-03	アボットダイアベティスケアインコーポレイテッド	エピソードの検出及び評価のためのシステム、装置、及び方法
CN105468894B (zh) *	2015-10-13	2018-11-06	腾讯科技（深圳）有限公司	一种体征数据显示方法及其设备
WO2017063199A1 (fr) *	2015-10-16	2017-04-20	深圳迈瑞生物医疗电子股份有限公司	Dispositif de surveillance et procédé d'affichage d'informations de surveillance
CN109475296B (zh)	2016-08-12	2022-04-05	德克斯康公司	用于连续葡萄糖监测的健康数据可视化和用户支持工具的系统和方法
CA3039212C (fr) *	2016-10-21	2022-12-13	Eric S. Carlsgaard	Procede d'accentuation de valeurs d'analyte pendant une fenetre therapeutique
TWI668664B (zh)	2017-01-16	2019-08-11	華廣生技股份有限公司	Method for dynamically analyzing blood sugar level, system thereof and computer program product
US20220375558A1 (en) *	2019-11-12	2022-11-24	Eli Lilly And Company	Systems and methods for displaying patient data
EP4298635A1 (fr) *	2021-02-25	2024-01-03	Dexcom, Inc.	Rapport de glucose et visualisation au meilleur jour
CN115732047A (zh) *	2021-08-27	2023-03-03	深圳硅基仿生科技股份有限公司	基于分析物数据的评估系统
CN115064239B (zh) *	2022-06-29	2025-04-25	上海联影医疗科技股份有限公司	虚拟生理信号生成方法、装置、设备、介质及程序产品

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060034538A1 (en)	2004-07-23	2006-02-16	Agfa Corporation	Method and system of automating echocardiogram measurements and reporting
US7344500B2 (en) *	2004-07-27	2008-03-18	Medtronic Minimed, Inc.	Sensing system with auxiliary display
US20070033074A1 (en) *	2005-06-03	2007-02-08	Medtronic Minimed, Inc.	Therapy management system
JP4802571B2 (ja) *	2005-06-24	2011-10-26	ソニー株式会社	ヘルプ画面自動表示機能付き受付装置、業務用受付装置、プリントキオスク装置、ヘルプ画面自動表示方法及びプログラム
US20070016449A1 (en) *	2005-06-29	2007-01-18	Gary Cohen	Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
US20080015422A1 (en) *	2005-12-29	2008-01-17	Guidance Interactive Healthcare, Inc.	Combined peripheral and health monitoring devices
US8564544B2 (en)	2006-09-06	2013-10-22	Apple Inc.	Touch screen device, method, and graphical user interface for customizing display of content category icons
EP1918837A1 (fr) *	2006-10-31	2008-05-07	F. Hoffmann-La Roche AG	Procédé de traitement d'une séquence chronologique de mesures d'un paramètre dépendant du temps
US20080300572A1 (en) *	2007-06-01	2008-12-04	Medtronic Minimed, Inc.	Wireless monitor for a personal medical device system
CN101896910A (zh) *	2007-12-10	2010-11-24	拜尔健康护理有限责任公司	用于健康测量的界面及监测系统
US20090158152A1 (en) *	2007-12-12	2009-06-18	Kodimer Marianne L	System and method for generating context sensitive help for a graphical user interface
JP2010069193A (ja) *	2008-09-22	2010-04-02	Panasonic Corp	生体情報収集システム
JP4522475B1 (ja) *	2009-03-19	2010-08-11	Ｓｍｋ株式会社	操作入力装置、制御方法、およびプログラム
EP2410910A4 (fr) *	2009-03-27	2014-10-15	Dexcom Inc	Procédés et systèmes favorisant la gestion du glucose
US20100279418A1 (en) *	2009-05-04	2010-11-04	Loren Robert Larson	Glucose meter adaptable for use with handheld devices, and associated communication network
BRPI1015133A2 (pt)	2009-06-30	2016-04-19	Lifescan Scotland Ltd	sistemas para o gerenciamento de diabetes e métodos

2011
- 2011-11-04 CA CA2818327A patent/CA2818327A1/fr not_active Abandoned
- 2011-11-04 WO PCT/US2011/059416 patent/WO2012067854A2/fr not_active Ceased
- 2011-11-04 JP JP2013539883A patent/JP5855118B2/ja not_active Expired - Fee Related
- 2011-11-04 CN CN201180055807.XA patent/CN103561634B/zh not_active Expired - Fee Related
- 2011-11-04 AU AU2011329302A patent/AU2011329302B2/en not_active Ceased
- 2011-11-04 RU RU2013127664/08A patent/RU2013127664A/ru unknown
- 2011-11-04 BR BR112013012462-8A patent/BR112013012462A2/pt not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN103561634A (zh)	2014-02-05
JP2014504174A (ja)	2014-02-20
BR112013012462A2 (pt)	2020-08-04
JP5855118B2 (ja)	2016-02-09
WO2012067854A3 (fr)	2013-11-28
AU2011329302B2 (en)	2016-09-15
AU2011329302A1 (en)	2013-06-06
RU2013127664A (ru)	2014-12-27
CN103561634B (zh)	2017-12-08
WO2012067854A2 (fr)	2012-05-24

Legal Events

Date	Code	Title	Description
2016-11-03	EEER	Examination request	Effective date: 20161101
2019-04-11	FZDE	Discontinued	Effective date: 20190228

Publication	Publication Date	Title
AU2011329302B2 (en)	2016-09-15	Analyte testing method and system with high and low analyte trends notification
US20130318439A1 (en)	2013-11-28	Analyte testing method and system with high and low analyte trends notification
US9563743B2 (en)	2017-02-07	Analyte testing method and system with high and low blood glucose trends notification
EP2455876A2 (fr)	2012-05-23	Système et procédé pour la gestion de diabète
KR20130116290A (ko)	2013-10-23	고 분석물 및 저 분석물 경향 통지를 갖는 분석물 검사 방법 및 시스템
HK1170816A (en)	2013-03-08	System and method for diabetes management
HK1212068B (en)	2021-01-08	Analyte testing method and system with high and low blood glucose trends notification
HK1170817A (en)	2013-03-08	System and method for diabetes management
HK1170815A (en)	2013-03-08	Method for diabetes management
HK40032388A (en)	2021-03-26	Analyte testing method and system with high and low blood glucose trends notification
HK1179361B (en)	2015-10-23	Analyte testing method and system with high and low blood glucose trends notification
HK1183720B (en)	2015-09-25	Analyte testing method and system with high and low blood glucose trends notification